Hohnloser SH - Search Results

1

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.

Cappato R, Marchlinski FE, Hohnloser SH, Naccarelli GV, Xiang J, Wilber DJ, Ma CS, Hess S, Wells DS, Juang G, Vijgen J, Hügl BJ, Balasubramaniam R, De Chillou C, Davies DW, Fields LE, Natale A; VENTURE-AF Investigators. Cappato R, et al. Among authors: hohnloser sh. Eur Heart J. 2015 Jul 21;36(28):1805-11. doi: 10.1093/eurheartj/ehv177. Epub 2015 May 14. Eur Heart J. 2015. PMID: 25975659 Free PMC article. Clinical Trial.

2

Recorded sudden cardiac death: relationship to antiarrhythmic therapy.

Hohnloser SH, Meinertz T. Hohnloser SH, et al. Eur Heart J. 1988 Feb;9 Suppl B:27-31. doi: 10.1093/eurheartj/9.suppl_b.27. Eur Heart J. 1988. PMID: 3286264 Review. No abstract available.

3

Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.

Naccarelli GV, Dorian P, Hohnloser SH, Coumel P. Naccarelli GV, et al. Among authors: hohnloser sh. Am J Cardiol. 1996 Jan 25;77(3):53A-59A. doi: 10.1016/s0002-9149(97)89118-7. Am J Cardiol. 1996. PMID: 8607392 Clinical Trial.

4

A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.

Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ. Dorian P, et al. Among authors: hohnloser sh. Am J Cardiol. 1996 Jan 25;77(3):89A-95A. doi: 10.1016/s0002-9149(97)89123-0. Am J Cardiol. 1996. PMID: 8607397 Clinical Trial.

5

Radiofrequency catheter ablation of atrial flutter after orthotopic heart transplantation.

Li YG, Grönefeld G, Hohnloser SH. Li YG, et al. Among authors: hohnloser sh. J Cardiovasc Electrophysiol. 1996 Nov;7(11):1086-90. doi: 10.1111/j.1540-8167.1996.tb00485.x. J Cardiovasc Electrophysiol. 1996. PMID: 8930741

6

Drug treatment of atrial fibrillation: what have we learned?

Hohnloser SH, Li YG. Hohnloser SH, et al. Curr Opin Cardiol. 1997 Jan;12(1):24-32. doi: 10.1097/00001573-199701000-00005. Curr Opin Cardiol. 1997. PMID: 9132077 Review.

7

Pharmacological therapy of atrial fibrillation.

Grönefeld G, Bender B, Li YG, Hohnloser SH. Grönefeld G, et al. Among authors: hohnloser sh. Thorac Cardiovasc Surg. 1999 Aug;47 Suppl 3:334-8. doi: 10.1055/s-2007-1013194. Thorac Cardiovasc Surg. 1999. PMID: 10520763 Review.

8

Pharmacological management of atrial fibrillation: an update.

Hohnloser SH, Li YG, Bender B, Grönefeld G. Hohnloser SH, et al. J Cardiovasc Pharmacol Ther. 2000 Jan;5(1):11-6. doi: 10.1177/107424840000500102. J Cardiovasc Pharmacol Ther. 2000. PMID: 10687669 Review.

9

Adenosine-induced atrial fibrillation.

Israel C, Klingenheben T, Grönefeld G, Hohnloser SH. Israel C, et al. Among authors: hohnloser sh. J Cardiovasc Electrophysiol. 2000 Jul;11(7):825. doi: 10.1111/j.1540-8167.2000.tb00057.x. J Cardiovasc Electrophysiol. 2000. PMID: 10921803 No abstract available.

10

Risk of development of delayed atrioventricular block after slow pathway modification in patients with atrioventricular nodal reentrant tachycardia and a pre-existing prolonged PR interval.

Li YG, Grönefeld G, Bender B, Machura C, Hohnloser SH. Li YG, et al. Among authors: hohnloser sh. Eur Heart J. 2001 Jan;22(1):89-95. doi: 10.1053/euhj.2000.2182. Eur Heart J. 2001. PMID: 11133214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

550 results

Search Page